AU1269192A - Pharmaceutical product for the therapy of tumors, particularly ovarian and haemopoietic system tumors, containing quercetin compounds as active substances - Google Patents

Pharmaceutical product for the therapy of tumors, particularly ovarian and haemopoietic system tumors, containing quercetin compounds as active substances

Info

Publication number
AU1269192A
AU1269192A AU12691/92A AU1269192A AU1269192A AU 1269192 A AU1269192 A AU 1269192A AU 12691/92 A AU12691/92 A AU 12691/92A AU 1269192 A AU1269192 A AU 1269192A AU 1269192 A AU1269192 A AU 1269192A
Authority
AU
Australia
Prior art keywords
tumors
therapy
active substances
pharmaceutical product
containing quercetin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12691/92A
Inventor
Pier Luigi Benedetti-Pacini
Arnaldo Cappelli
Giancarlo Folchitto
Salvatore Mancuso
Mauro Piantelli
Franco Oreste Ranelletti
Giovanni Scambia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1269192A publication Critical patent/AU1269192A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU12691/92A 1991-02-05 1992-01-31 Pharmaceutical product for the therapy of tumors, particularly ovarian and haemopoietic system tumors, containing quercetin compounds as active substances Abandoned AU1269192A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM91A000085 1991-02-05
ITRM910085A IT1244647B (en) 1991-02-05 1991-02-05 PHARMACEUTICAL PRODUCT FOR CANCER THERAPY, IN PARTICULAR OF OVARIAN AND HEMOPOIETIC SYSTEM, CONTAINING QUERCITIN AS AN ACTIVE PRINCIPLE.

Publications (1)

Publication Number Publication Date
AU1269192A true AU1269192A (en) 1992-09-07

Family

ID=11399834

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12691/92A Abandoned AU1269192A (en) 1991-02-05 1992-01-31 Pharmaceutical product for the therapy of tumors, particularly ovarian and haemopoietic system tumors, containing quercetin compounds as active substances

Country Status (5)

Country Link
EP (1) EP0570475A1 (en)
JP (1) JPH07502009A (en)
AU (1) AU1269192A (en)
IT (1) IT1244647B (en)
WO (1) WO1992013851A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20010600A1 (en) * 2001-10-04 2003-04-04 Brane Tech S R L FLAVONOID COMPOUNDS CAPABLE OF MODIFYING THE PHYSICAL AND / OR DYNAMIC STATE OF BIOLOGICAL MEMBRANES AND OF STIMULATING THE ENDOGENIC SYNTHESIS OF PROTEIN
CN105748402B (en) * 2010-11-24 2022-06-03 杜雷科特公司 Biodegradable drug delivery compositions
KR102173501B1 (en) 2012-11-26 2020-11-04 액세스 비지니스 그룹 인터내셔날 엘엘씨 Antioxidant dietary supplement and related method
CN111068095B (en) * 2020-02-07 2021-07-13 中国科学院上海硅酸盐研究所 Bioactive ion modified quercetin chelating agent composition for efficiently inducing regeneration of hair follicles of burn wound surfaces and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2892845A (en) * 1957-11-26 1959-06-30 Jurd Leonard Selective etherification of the 7-hydroxyl group in polyhydroxy flavonoids
FR3541M (en) * 1964-05-12 1965-09-13 Laroche Navarron Lab Drug has natriuretic properties based on a new flavone.

Also Published As

Publication number Publication date
EP0570475A1 (en) 1993-11-24
IT1244647B (en) 1994-08-08
ITRM910085A1 (en) 1992-08-05
JPH07502009A (en) 1995-03-02
ITRM910085A0 (en) 1991-02-05
WO1992013851A1 (en) 1992-08-20

Similar Documents

Publication Publication Date Title
AU5112993A (en) Process for the preparation of drug pellets
AU4449789A (en) Delivery system for pharmaceutical or therapeutic actives
IL91360A0 (en) Cyclodextrin derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL96019A0 (en) Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
NO944700D0 (en) New Thienothiazine Derivatives, Process for their Preparation and Pharmaceutical Preparations Containing the Compounds
IL112779A (en) Granular product or tablet containing an efferescent system and an active pharmaceutical substance and its preparation
NO305903B1 (en) Benzonitriles and benzofluorides, drugs comprising the compounds, pharmaceutical compositions containing the compounds, and use of the compounds for the preparation of pharmaceutical preparations
HU9301700D0 (en) Methods for producing biphenylic derivatives and pharmaceutical preparatives containing them as active substance
AU1594892A (en) New benzopyran compounds, process for preparing these and pharmaceutical compositions containing them
AU5108196A (en) Imidazoquinazolines, drugs containing these compounds, their use and process for their preparation
AU5339594A (en) Novel taxane derivatives, their preparation and pharmaceutical compositions containing them
ZA934037B (en) Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same.
AU1811495A (en) Granular product or tablet containing an effervescent system and an active pharmaceutical substance, as well as a method for its preparation
AU3505093A (en) Novel baccatine III and 10-deacetyl baccatine III derivatives, their preparation, and pharmaceutical compositions containing same
AU4856290A (en) Stabilizing system for solid dosage forms
IL104471A0 (en) Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
AU1269192A (en) Pharmaceutical product for the therapy of tumors, particularly ovarian and haemopoietic system tumors, containing quercetin compounds as active substances
AU4045489A (en) Silver sulfadiazine containing pharmaceutical product for the local external therapy
EP0572308A3 (en) Heterocyclic derivatives, process for their preparation and pharmaceutical compositions containing them.
AU3019389A (en) 6-oxo-4,5-dihydro-pyridazine derivatives, a process for their preparation and medicaments containing these compounds
MY115795A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
AU4442996A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and pharmaceutical preparations containing them
AU4756693A (en) 1-heteroarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them
AU2626392A (en) Use of substituted pyrrolidines, some of which are known, as medicaments, new active substances and processes for their preparation
AU2626292A (en) Use of substituted tetrahydrothiophenes, some of which are known, as medicaments, new active substances and processes for their preparation